Insomnia Treatment Market
Insomnia Treatment Market Size, Share & Trends Analysis Report, By Treatment Type (Pharmacological Treatment, Non-Pharmacological Treatment), By Drug Class (Benzodiazepines, Non-benzodiazepine Hypnotics, Orexin Receptor Antagonists, Antidepressants, Melatonin Receptor Agonists), By Therapy Type (Cognitive Behavioural Therapy (CBT-I), Sleep Hygiene Education Programs, Relaxation Techniques & Mindfulness Therapy, Digital Therapeutics / App-based Sleep Programs), By End Users (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct-to-Consumer Digital Platforms), Forecast Period (2026-2035)
Industry Overview
Insomnia treatment market size was valued at $3.10 billion in 2025 and is projected to reach $4.85 billion by 2035, growing at a CAGR of 4.6% between 2026 and 2035. The market includes pharmacological and non-pharmacological therapies designed to treat insomnia and related sleep disorders. Insomnia is one of the most common neurological conditions globally, driven by increasing stress levels, mental health disorders, and lifestyle changes. According to the World Health Organization, sleep disorders are closely associated with chronic diseases and mental health conditions, significantly increasing global healthcare burden. A key driver supporting market growth is the rising prevalence of anxiety, depression, and lifestyle-related disorders. Data from IQVIA indicates a steady increase in prescription drug usage for central nervous system disorders, including insomnia. Additionally, advancements in orexin receptor antagonists and digital therapeutics are enhancing treatment effectiveness. Insomnia treatment solutions are widely adopted across hospitals, pharmacies, and digital healthcare platforms, supporting improved patient outcomes and long-term disease management.
Market Dynamics
Rising Prevalence of Sleep Disorders Driving Market Growth
The increasing incidence of insomnia and sleep-related disorders is a major factor driving the insomnia treatment market. According to the Organisation for Economic Co-operation and Development, mental health disorders are rising globally, with sleep disturbances being a key symptom, thereby increasing demand for effective treatment options. Additionally, growing awareness about the importance of sleep health and early diagnosis is supporting market expansion. Healthcare providers and pharmaceutical companies are increasingly focusing on developing advanced drug formulations and innovative therapies between 2023 and 2026. The introduction of orexin receptor antagonists and melatonin receptor agonists is improving treatment outcomes while reducing side effects. Furthermore, the rapid expansion of telehealth services and digital therapeutic platforms is enhancing patient access to insomnia treatment, particularly in developed economies.
Drug Dependency and Side Effects Limiting Market Growth
Despite strong demand, the insomnia treatment market faces challenges associated with drug dependency and adverse effects. Benzodiazepines and certain hypnotics can lead to tolerance, withdrawal symptoms, and long-term health risks, limiting their use. According to the U.S. Food and Drug Administration, strict regulations on sedative-hypnotic drugs are necessary due to safety concerns, which can impact market growth. Additionally, the high cost of advanced therapies and limited access to non-pharmacological treatments in developing regions pose significant barriers. Cognitive behavioural therapy for insomnia (CBT-I), while effective, requires trained professionals and structured healthcare systems. To address these challenges, companies are focusing on developing safer drugs, expanding digital therapy solutions, and investing in personalized treatment approaches to improve accessibility and effectiveness.
Market Segmentation
- Based on the treatment type, the market is segmented into pharmacological treatment and non-pharmacological treatment.
- Based on the drug class, the market is segmented into benzodiazepines, non-benzodiazepine hypnotics, orexin receptor antagonists, antidepressants, and melatonin receptor agonists.
- Based on the therapy type, the market is segmented into cognitive behavioural therapy (CBT-I), sleep hygiene education programs, relaxation techniques & mindfulness therapy, and digital therapeutics / app-based sleep programs.
- Based on the end users, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and direct-to-consumer digital platforms.
Pharmacological Treatment Segment Leads the Market
The pharmacological treatment segment holds a dominant position in the insomnia treatment market due to its widespread adoption for immediate symptom relief. Prescription medications such as benzodiazepines, non-benzodiazepine hypnotics, and melatonin receptor agonists are commonly used across healthcare settings. Increasing patient demand for quick and effective treatment solutions is driving segment growth. Pharmaceutical companies have been actively investing in the development of safer and more targeted drugs between 2022 and 2026. The introduction of orexin receptor antagonists is improving efficacy while reducing side effects. Additionally, increasing healthcare expenditure and improved drug accessibility are supporting the dominance of this segment.
Digital Therapeutics / App-based Sleep Programs Segment to Record Strong Growth
The digital therapeutics and app-based sleep programs segment is expected to witness strong growth due to the increasing adoption of technology-driven healthcare solutions. These platforms offer personalized treatment, behavioural therapy, and real-time monitoring, improving patient adherence and outcomes. The rise of telemedicine and mobile health applications is accelerating the adoption of digital therapeutics. Increasing investments in digital health infrastructure and growing awareness of non-pharmacological treatments are key factors driving segment growth. Additionally, the need to reduce dependency on drugs is further supporting the expansion of this segment.
Regional Outlook
The global insomnia treatment market is geographically segmented into North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa and Latin America).
United States Leads the Market
The United States dominates the insomnia treatment market due to high prevalence of sleep disorders and advanced healthcare infrastructure. According to the Centers for Disease Control and Prevention, a significant percentage of adults report insufficient sleep, driving demand for treatment solutions. High healthcare spending and rapid adoption of advanced therapies further support market growth.
China to Record Strong Growth
China is expected to witness strong growth due to increasing healthcare investments and rising awareness of mental health. According to the International Trade Centre, China’s expanding pharmaceutical industry is supporting the development and adoption of advanced treatment solutions. Urbanization and lifestyle changes are further contributing to increased prevalence of insomnia.
Competitive Landscape
The insomnia treatment market is highly competitive, driven by innovation and increasing demand for effective therapies. Leading companies such as Eisai Co., Ltd., Idorsia Pharmaceuticals Ltd., Merck & Co., Inc., Takeda Pharmaceutical Company Limited, and Vanda Pharmaceuticals Inc. are focusing on expanding their product portfolios and strengthening their market position through research, innovation, and strategic collaborations.
Recent Developments
- In March 2026, Idorsia Ltd entered into an exclusive distribution and commercialization agreement with Pharma link Drug Store L.L.C for QUVIVIQ (daridorexant) across the UAE, Kuwait, Qatar, Oman, and Bahrain. This strategic collaboration aims to expand Idorsia’s presence in the Middle East insomnia treatment market while improving regional patient access to innovative sleep disorder therapies.
- In March 2026, Vanda Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration granted a formal evidentiary public hearing to review the proposed refusal of its supplemental NDA for HETLIOZ (tasimelteon) in treating jet lag disorder. This rare regulatory decision, not granted in decades, highlights the significance of the scientific and legal considerations involved, while supporting Vanda’s efforts to expand therapeutic indications and improve treatment options for sleep-related disorders globally.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualised market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global insomnia treatment market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Insomnia Treatment Market Sales Analysis – Treatment Type | Drug Class | Therapy Type | End Users ($ Million)
- Insomnia Treatment Market Sales Performance of Top Countries
1.1 Research Methodology
- Primary Research Approach
- Secondary Research Approach
1.2 Market Snapshot
- Market Overview and Insights
2.1 Scope of the Study
2.2 Analyst Insight & Current Market Trends
2.2.1 Key Insomnia Treatment Market Trends
2.2.2 Market Recommendations
2.3 Porter's Five Forces Analysis for the Insomnia Treatment Market
2.3.1 Competitive Rivalry
2.3.2 Threat of New Entrants
2.3.3 Bargaining Power of Suppliers
2.3.4 Bargaining Power of Buyers
2.3.5 Threat of Substitutes
- Market Determinants
3.1 Market Drivers
3.1.1 Drivers For Global Insomnia Treatment Market: Impact Analysis
3.2 Market Pain Points and Challenges
3.2.1 Restraints For Global Insomnia Treatment Market: Impact Analysis
3.3 Market Opportunities
3.3.1 Opportunities For Global Insomnia Treatment Market: Impact Analysis
- Competitive Landscape
4.1 Competitive Dashboard – Insomnia Treatment Market Revenue and Share by Manufacturers
- Insomnia Treatment Product Comparison Analysis
- Top Market Player Ranking Matrix
4.2 Key Company Analysis
4.2.1 Eisai Co., Ltd.
4.2.1.1 Overview
4.2.1.2 Product Portfolio
4.2.1.3 Financial Analysis
4.2.1.4 SWOT Analysis
4.2.1.5 Business Strategy
4.2.2 Idorsia Pharmaceuticals Ltd.
4.2.2.1 Overview
4.2.2.2 Product Portfolio
4.2.2.3 Financial Analysis
4.2.2.4 SWOT Analysis
4.2.2.5 Business Strategy
4.2.3 Merck & Co., Inc.
4.2.3.1 Overview
4.2.3.2 Product Portfolio
4.2.3.3 Financial Analysis
4.2.3.4 SWOT Analysis
4.2.3.5 Business Strategy
4.2.4 Takeda Pharmaceutical Company Limited
4.2.4.1 Overview
4.2.4.2 Product Portfolio
4.2.4.3 Financial Analysis
4.2.4.4 SWOT Analysis
4.2.4.5 Business Strategy
4.2.5 Vanda Pharmaceuticals Inc.
4.2.5.1 Overview
4.2.5.2 Product Portfolio
4.2.5.3 Financial Analysis
4.2.5.4 SWOT Analysis
4.2.5.5 Business Strategy
4.3 Top Winning Strategies by Market Players
4.3.1 Merger and Acquisition
4.3.2 Product Launch
4.3.3 Partnership And Collaboration
- Global Insomnia Treatment Market Sales Analysis by Treatment Type ($ Million)
5.1 Pharmacological Treatment
5.2 Non-Pharmacological Treatment
- Global Insomnia Treatment Market Sales Analysis by Drug Class ($ Million)
6.1 Benzodiazepines
6.2 Non-benzodiazepine Hypnotics
6.3 Orexin Receptor Antagonists
6.4 Antidepressants
6.5 Melatonin Receptor Agonists
- Global Insomnia Treatment Market Sales Analysis by Therapy Type ($ Million)
7.1 Cognitive Behavioural Therapy (CBT-I)
7.2 Sleep Hygiene Education Programs
7.3 Relaxation Techniques & Mindfulness Therapy
7.4 Digital Therapeutics / App-based Sleep Programs
- Global Insomnia Treatment Market Sales Analysis by End Users ($ Million)
8.1 Hospital Pharmacies
8.2 Retail Pharmacies
8.3 Online Pharmacies
8.4 Direct-to-Consumer Digital Platforms
- Regional Analysis
9.1 North American Insomnia Treatment Market Sales Analysis – Treatment Type | Drug Class | Therapy Type | End Users ($ Million)
9.1.1 United States
9.1.2 Canada
9.2 European Insomnia Treatment Market Sales Analysis – Treatment Type | Drug Class | Therapy Type | End Users ($ Million)
9.2.1 UK
9.2.2 Germany
9.2.3 Italy
9.2.4 Spain
9.2.5 France
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Asia-Pacific Insomnia Treatment Market Sales Analysis – Treatment Type | Drug Class | Therapy Type | End Users ($ Million)
9.3.1 China
9.3.2 Japan
9.3.3 South Korea
9.3.4 India
9.3.5 Australia & New Zealand
9.3.6 ASEAN Countries
9.3.7 Rest of Asia-Pacific
9.4 Rest of the World Insomnia Treatment Market Sales Analysis – Treatment Type | Drug Class | Therapy Type | End Users ($ Million)
9.4.1 Latin America
9.4.2 Middle East and Africa
- Company Profiles
10.1 Sanofi S.A.
10.1.1 Quick Facts
10.1.2 Company Overview
10.1.3 Product Portfolio
10.1.4 Business Strategies
10.2 Sumitomo Pharma Co., Ltd.
10.2.1 Quick Facts
10.2.2 Company Overview
10.2.3 Product Portfolio
10.2.4 Business Strategies
10.3 Viatris Inc.
10.3.1 Quick Facts
10.3.2 Company Overview
10.3.3 Product Portfolio
10.3.4 Business Strategies
10.4 Pfizer Inc.
10.4.1 Quick Facts
10.4.2 Company Overview
10.4.3 Product Portfolio
10.4.4 Business Strategies
10.5 Roche Holding AG
10.5.1 Quick Facts
10.5.2 Company Overview
10.5.3 Product Portfolio
10.5.4 Business Strategies
10.6 GlaxoSmithKline plc
10.6.1 Quick Facts
10.6.2 Company Overview
10.6.3 Product Portfolio
10.6.4 Business Strategies
10.7 Big Health Ltd.
10.7.1 Quick Facts
10.7.2 Company Overview
10.7.3 Product Portfolio
10.7.4 Business Strategies
10.8 ResMed Inc.
10.8.1 Quick Facts
10.8.2 Company Overview
10.8.3 Product Portfolio
10.8.4 Business Strategies
10.9 Apollo Neuroscience, Inc.
10.9.1 Quick Facts
10.9.2 Company Overview
10.9.3 Product Portfolio
10.9.4 Business Strategies
10.10 Somnox B.V.
10.10.1 Quick Facts
10.10.2 Company Overview
10.10.3 Product Portfolio
10.10.4 Business Strategies
10.11 Fisher Wallace Laboratories
10.11.1 Quick Facts
10.11.2 Company Overview
10.11.3 Product Portfolio
10.11.4 Business Strategies
10.12 Haleon plc
10.12.1 Quick Facts
10.12.2 Company Overview
10.12.3 Product Portfolio
10.12.4 Business Strategies
10.13 ZzzQuil
10.13.1 Quick Facts
10.13.2 Company Overview
10.13.3 Product Portfolio
10.13.4 Business Strategies
10.14 Johnson & Johnson
10.14.1 Quick Facts
10.14.2 Company Overview
10.14.3 Product Portfolio
10.14.4 Business Strategies
10.15 Bayer AG
10.15.1 Quick Facts
10.15.2 Company Overview
10.15.3 Product Portfolio
10.15.4 Business Strategies
10.16 Curable, Inc.
10.16.1 Quick Facts
10.16.2 Company Overview
10.16.3 Product Portfolio
10.16.4 Business Strategies
10.17 Teijin Limited
10.17.1 Quick Facts
10.17.2 Company Overview
10.17.3 Product Portfolio
10.17.4 Business Strategies
10.18 Dreem Health
10.18.1 Quick Facts
10.18.2 Company Overview
10.18.3 Product Portfolio
10.18.4 Business Strategies
10.19 Oura Health Oy
10.19.1 Quick Facts
10.19.2 Company Overview
10.19.3 Product Portfolio
10.19.4 Business Strategies
10.20 Flynn Pharma Ltd.
10.20.1 Quick Facts
10.20.2 Company Overview
10.20.3 Product Portfolio
10.20.4 Business Strategies
1. Global Insomnia Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million)
2. Global Pharmacological Insomnia Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Non-Pharmacological Insomnia Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Insomnia Treatment Market Research and Analysis by Drug Class, 2025–2035 ($ Million)
5. Global Benzodiazepines Insomnia Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Non-benzodiazepine Hypnotics Insomnia Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Orexin Receptor Antagonists Insomnia Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Antidepressants Insomnia Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Melatonin Receptor Agonists Insomnia Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Insomnia Treatment Market Research and Analysis by Therapy Type, 2025–2035 ($ Million)
11. Global Cognitive Behavioural Therapy Insomnia Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Sleep Hygiene Education Programs Insomnia Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
13. Global Relaxation Techniques & Mindfulness Therapy Insomnia Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Global Digital Therapeutics Insomnia Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
15. Global Insomnia Treatment Market Research and Analysis by End Users, 2025–2035 ($ Million)
16. Global Insomnia Treatment for Hospital Pharmacies Research and Analysis by Region, 2025–2035 ($ Million)
17. Global Insomnia Treatment for Retail Pharmacies Research and Analysis by Region, 2025–2035 ($ Million)
18. Global Insomnia Treatment for Online Pharmacies Research and Analysis by Region, 2025–2035 ($ Million)
19. Global Insomnia Treatment for Direct-to-Consumer Digital Platforms Research and Analysis by Region, 2025–2035 ($ Million)
20. Global Insomnia Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
21. North America Insomnia Treatment Market Research and Analysis by Country, 2025–2035 ($ Million)
22. Europe Insomnia Treatment Market Research and Analysis by Country, 2025–2035 ($ Million)
23. Asia-Pacific Insomnia Treatment Market Research and Analysis by Country, 2025–2035 ($ Million)
24. Rest of the World Insomnia Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
1. Global Insomnia Treatment Market Share by Treatment Type, 2025 Vs 2035 (%)
2. Global Pharmacological Insomnia Treatment Market Share by Region, 2025 Vs 2035 (%)
3. Global Non-Pharmacological Insomnia Treatment Market Share by Region, 2025 Vs 2035 (%)
4. Global Insomnia Treatment Market Share by Drug Class, 2025 Vs 2035 (%)
5. Global Benzodiazepines Insomnia Treatment Market Share by Region, 2025 Vs 2035 (%)
6. Global Non-benzodiazepine Hypnotics Insomnia Treatment Market Share by Region, 2025 Vs 2035 (%)
7. Global Orexin Receptor Antagonists Insomnia Treatment Market Share by Region, 2025 Vs 2035 (%)
8. Global Antidepressants Insomnia Treatment Market Share by Region, 2025 Vs 2035 (%)
9. Global Melatonin Receptor Agonists Insomnia Treatment Market Share by Region, 2025 Vs 2035 (%)
10. Global Insomnia Treatment Market Share by Therapy Type, 2025 Vs 2035 (%)
11. Global Cognitive Behavioural Therapy Insomnia Treatment Market Share by Region, 2025 Vs 2035 (%)
12. Global Sleep Hygiene Education Programs Insomnia Treatment Market Share by Region, 2025 Vs 2035 (%)
13. Global Relaxation Techniques & Mindfulness Therapy Insomnia Treatment Market Share by Region, 2025 Vs 2035 (%)
14. Global Digital Therapeutics Insomnia Treatment Market Share by Region, 2025 Vs 2035 (%)
15. Global Insomnia Treatment Market Share by End Users, 2025 Vs 2035 (%)
16. Global Insomnia Treatment Market Share by Region, 2025 Vs 2035 (%)
17. US Insomnia Treatment Market Size, 2025–2035 ($ Million)
18. Canada Insomnia Treatment Market Size, 2025–2035 ($ Million)
19. UK Insomnia Treatment Market Size, 2025–2035 ($ Million)
20. France Insomnia Treatment Market Size, 2025–2035 ($ Million)
21. Germany Insomnia Treatment Market Size, 2025–2035 ($ Million)
22. Italy Insomnia Treatment Market Size, 2025–2035 ($ Million)
23. Spain Insomnia Treatment Market Size, 2025–2035 ($ Million)
24. Russia Insomnia Treatment Market Size, 2025–2035 ($ Million)
25. India Insomnia Treatment Market Size, 2025–2035 ($ Million)
26. China Insomnia Treatment Market Size, 2025–2035 ($ Million)
27. Japan Insomnia Treatment Market Size, 2025–2035 ($ Million)
28. South Korea Insomnia Treatment Market Size, 2025–2035 ($ Million)
29. Australia & New Zealand Insomnia Treatment Market Size, 2025–2035 ($ Million)
30. ASEAN Insomnia Treatment Market Size, 2025–2035 ($ Million)
31. Rest of Asia-Pacific Insomnia Treatment Market Size, 2025–2035 ($ Million)
32. Latin America Insomnia Treatment Market Size, 2025–2035 ($ Million)
33. Middle East & Africa Insomnia Treatment Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
